95 related articles for article (PubMed ID: 6188365)
21. Comparative evaluation of flow-cytometric immunophenotyping and immunocytochemistry in the categorization of malignant small round cell tumors in fine-needle aspiration cytologic specimens.
Gautam U; Srinivasan R; Rajwanshi A; Bansal D; Marwaha RK
Cancer; 2008 Dec; 114(6):494-503. PubMed ID: 19073016
[TBL] [Abstract][Full Text] [Related]
22. Class II alloantigen expression on leukemic cells.
Falkenrodt A; Urlacher A; Mayer S; Bergerat JP; Boilletot A; Lutz P; Griveau AM; Troussard S; Mitsuichi Y; Dormoy A
Nouv Rev Fr Hematol (1978); 1989; 31(3):209-16. PubMed ID: 2694093
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata.
Brouet JC; Labaume S; Seligmann M
Br J Cancer Suppl; 1975 Mar; 2():121-7. PubMed ID: 1081001
[TBL] [Abstract][Full Text] [Related]
24. Antimyosin and antirhabdomyoblast sera: their use for the diagnosis of childhood rhabdomyosarcoma.
Koh SJ; Johnson WW
Arch Pathol Lab Med; 1980 Mar; 104(3):118-22. PubMed ID: 6892593
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic utility of cyclin D1 in the diagnosis of small round blue cell tumors in children and adolescents.
Magro G; Salvatorelli L; Alaggio R; D'Agata V; Nicoletti F; Di Cataldo A; Parenti R
Hum Pathol; 2017 Feb; 60():58-65. PubMed ID: 27984122
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic characterization of non-haemopoietic small cell tumours of childhood with monoclonal antibodies to leucocytes, epithelial cells and cytoskeletal proteins.
Pilkington GR; Pallesen G
Histopathology; 1989 Apr; 14(4):347-57. PubMed ID: 2544500
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical analysis of human MHC class II antigens in B-cell non-Hodgkin's lymphomas.
Krajewski AS; Guy K; Dewar AE; Cossar D
J Pathol; 1985 Feb; 145(2):185-94. PubMed ID: 2579225
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis of neuroblastoma metastasis in bone marrow with a panel of monoclonal antibodies.
Sugimoto T; Sawada T; Matsumura T; Kemshead JT; Horii Y; Saida T; Imashuku S; Takeuchi Y
Med Pediatr Oncol; 1988; 16(3):190-6. PubMed ID: 3288854
[TBL] [Abstract][Full Text] [Related]
29. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
Pinkus GS; Said JW
Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of surface membrane antigens, cytoskeletal proteins and N-myc oncogene in pediatric solid malignant tumors, their diagnostic usefulness and relevant problems].
Sugimoto T; Matsumura T; Horii Y; Saida T; Hosoi H; Saida T; Mine H; Sawada T
Hum Cell; 1992 Mar; 5(1):1-11. PubMed ID: 1329930
[TBL] [Abstract][Full Text] [Related]
31. Biochemical and genetic characterization of the HBA71 Ewing's sarcoma cell surface antigen.
Fellinger EJ; Garin-Chesa P; Su SL; DeAngelis P; Lane JM; Rettig WJ
Cancer Res; 1991 Jan; 51(1):336-40. PubMed ID: 1988096
[TBL] [Abstract][Full Text] [Related]
32. Differentiating lymphoblastic lymphoma and Ewing's sarcoma: lymphocyte markers and gene rearrangement.
Ozdemirli M; Fanburg-Smith JC; Hartmann DP; Azumi N; Miettinen M
Mod Pathol; 2001 Nov; 14(11):1175-82. PubMed ID: 11706081
[TBL] [Abstract][Full Text] [Related]
33. Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors.
Wehrli BM; Huang W; De Crombrugghe B; Ayala AG; Czerniak B
Hum Pathol; 2003 Mar; 34(3):263-9. PubMed ID: 12673561
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
[TBL] [Abstract][Full Text] [Related]
35. [Immunodiagnosis of chronic lymphatic leukemia and leukemic non-Hodgkin's lymphoma with the monoclonal antibodies BL-Ig-L/1, BL-DR/1 and BL-T2].
Malberg K; Fischer H; Elendt D; Wutke K; Fiebig H
Arch Geschwulstforsch; 1984; 54(4):325-32. PubMed ID: 6437368
[TBL] [Abstract][Full Text] [Related]
36. Chronic lymphocytic leukemia and other chronic lymphoid proliferations: surface marker phenotypes and clinical correlations.
Dillman RO; Beauregard JC; Lea JW; Green MR; Sobol RE; Royston I
J Clin Oncol; 1983 Mar; 1(3):190-7. PubMed ID: 6607975
[TBL] [Abstract][Full Text] [Related]
37. Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes.
van Dongen JJ; Hooijkaas H; Comans-Bitter M; Hählen K; de Klein A; van Zanen GE; van't Veer MB; Abels J; Benner R
J Immunol; 1985 Nov; 135(5):3144-50. PubMed ID: 2413114
[TBL] [Abstract][Full Text] [Related]
38. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
[TBL] [Abstract][Full Text] [Related]
40. Immunopathology of cutaneous T-cell lymphomas.
Nasu K; Said J; Vonderheid E; Olerud J; Sako D; Kadin M
Am J Pathol; 1985 Jun; 119(3):436-47. PubMed ID: 3893149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
